| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4003685 | American Journal of Ophthalmology | 2010 | 5 Pages |
Abstract
Long-term treatment with anti-VEGF agents did not lead to significant changes in RNFL thickness in a patient population with wet ARMD. Despite the possibility of repeated intraocular pressure (IOP) fluctuations after intravitreal injections and known neurotrophic properties of VEGF in the eye, chronic therapy with intravitreal anti-VEGF agents does not appear to adversely affect RNFL thickness. Further prospective studies with longer follow-up are needed to corroborate the findings of this study.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Michael B. Horsley, Naresh Mandava, Marco A. Maycotte, Malik Y. Kahook,